nsv997148
- Organism: Homo sapiens
- Study:nstd45 (ClinGen Curated Dosage Sensitivity Map-obsoleted)
- Variant Type:copy number variation
- Method Type:
- Submitted on:GRCh37 (hg19)
- Variant Calls:0
- Validation:Not tested
- Clinical Assertions: No
- Region Size:6,356
- Description:RAB39B;This region was evaluated in the context of an affected MALE. Please review disease-specific literature for information regarding phenotype of this disorder in FEMALES.
- Publication(s):Barbe et al. 2008, Cheng et al. 2002, Gerhard et al. 2004, Giannandrea et al. 2010, Hartley et al. 2000, Mehrle et al. 2006, Ota et al. 2004, Piton et al. 2013, Riggs et al. 2011, Ross et al. 2005, Simpson et al. 2000, Strausberg et al. 2002, Vissers et al. 2010, Wiemann et al. 2001, Wiemann et al. 2004
- ClinGen: RAB39B
- GENE: 116442
- OMIM: 300774
- PubMed: 11076863
- PubMed: 11230166
- PubMed: 11256614
- PubMed: 12438742
- PubMed: 12477932
- PubMed: 14702039
- PubMed: 15489334
- PubMed: 15489336
- PubMed: 15772651
- PubMed: 16381901
- PubMed: 18029348
- PubMed: 20159109
- PubMed: 21076407
- PubMed: 23871722
- Overlapping Genes
Source: NCBI
- Genome View
- Variant Region Details and Evidence
- Validation Information
- Clinical Assertions
- Genotype Information
Genome View
Select assembly:Overlapping variant regions from other studies: 269 SVs from 26 studies. See in: genome view
Overlapping variant regions from other studies: 261 SVs from 26 studies. See in: genome view
Variant Region Placement Information
Variant Region ID | Placement Type | Score | Assembly | Assembly Unit | Reciprocity | Sequence ID | Chr | Inner Start | Inner Stop |
---|---|---|---|---|---|---|---|---|---|
nsv997148 | Remapped | Perfect | GRCh38.p12 | Primary Assembly | First Pass | NC_000023.11 | ChrX | 155,258,234 | 155,264,589 |
nsv997148 | Submitted genomic | GRCh37 (hg19) | Primary Assembly | NC_000023.10 | ChrX | 154,487,519 | 154,493,874 |
Variant Call Information
Variant Call ID | Type | Method | Analysis | Subject Phenotype | Clinical Interpretation | Source of Interpretation | Copy number |
---|---|---|---|---|---|---|---|
nssv3442656 | copy number loss | Curated | Curated | RAS-ASSOCIATED PROTEIN RAB39B; RAB39B | Pathogenic | ClinGen Dosage Sensitivity Map | 0 |
Variant Call Placement Information
Variant Call ID | Placement Type | Score | HGVS | Assembly | Reciprocity | Sequence ID | Chr | Inner Start | Inner Stop |
---|---|---|---|---|---|---|---|---|---|
nssv3442656 | Remapped | Perfect | NC_000023.11:g.(?_ 155258234)_(155264 589_?)del | GRCh38.p12 | First Pass | NC_000023.11 | ChrX | 155,258,234 | 155,264,589 |
nssv3442656 | Submitted genomic | NC_000023.10:g.(?_ 154487519)_(154493 874_?)del | GRCh37 (hg19) | NC_000023.10 | ChrX | 154,487,519 | 154,493,874 |
No validation data were submitted for this variant
Clinical Assertions
Variant Call ID | HGVS | Type | Subject Phenotype | Clinical Interpretation | Source of Interpretation | Copy number |
---|---|---|---|---|---|---|
nssv3442656 | GRCh37: NC_000023.10:g.(?_154487519)_(154493874_?)del | copy number loss | RAS-ASSOCIATED PROTEIN RAB39B; RAB39B | Pathogenic | ClinGen Dosage Sensitivity Map | 0 |